Insertion Distance of Interscalene Perineural Catheters in the Context of Shoulder Surgery.
Influence of the Insertion Distance on Loss of Sensation Produced by Interscalene Perineural Catheters in the Context of Shoulder Surgery.
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is designed to compare interscalene catheter insertion distances, in order to determine which is the best for pain relief after shoulder surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Sep 2008
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 15, 2008
CompletedFirst Posted
Study publicly available on registry
September 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedMay 28, 2010
May 1, 2010
1.7 years
September 15, 2008
May 27, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensory block assessment
24 hours after surgery
Secondary Outcomes (1)
Quality of pain relief
24 hours after surgery
Study Arms (2)
1
ACTIVE COMPARATOR2
ACTIVE COMPARATORInterventions
Distance of interscalene catheter: 2cm
Eligibility Criteria
You may qualify if:
- Patients aged 18 years and older undergoing elective shoulder surgery
You may not qualify if:
- Severe COPD
- Coagulopathy
- Allergy to local anesthetics
- Chronic use of opioids
- Peripheral neuropathy of the operated limb
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de l'Université de Montréal (Hôpital Notre-Dame)
Montreal, Quebec, H2L 4M1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geneviève Arcand, MD, FRCPC
Centre hospitalier de l'Université de Montréal (CHUM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 15, 2008
First Posted
September 17, 2008
Study Start
September 1, 2008
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
May 28, 2010
Record last verified: 2010-05